Integration of palliative care into standard oncology care: American society of clinical oncology clinical practice guideline update

Purpose To provide evidence-based recommendations to oncology clinicians, patients, family and friend caregivers, and palliative care specialists to update the 2012 American Society of Clinical Oncology (ASCO) provisional clinical opinion (PCO) on the integration of palliative care into standard oncology care for all patients diagnosed with cancer. Methods ASCO convened an Expert Panel of members of the ASCO Ad Hoc Palliative Care Expert Panel to develop an update. The 2012 PCO was based on a review of a randomized controlled trial (RCT) by the National Cancer Institute Physicians Data Query and additional trials. The panel conducted an updated systematic review seeking randomized clinical trials, systematic reviews, and metaanalyses, as well as secondary analyses of RCTs in the 2012 PCO, published from March 2010 to January 2016. Results The guideline update reflects changes in evidence since the previous guideline. Nine RCTs, one quasiexperimental trial, and five secondary analyses from RCTs in the 2012 PCO on providing palliative care services to patients with cancer and/or their caregivers, including family caregivers, were found to inform the update. Recommendations Inpatients and outpatients with advanced cancer should receive dedicated palliative care services, early in the disease course, concurrent with active treatment. Referral of patients to interdisciplinary palliative care teams is optimal, and services may complement existing programs. Providers may refer family and friend caregivers of patients with early or advanced cancer to palliative care services

Clinical management of pain in advanced lung cancer

Lung cancer is the most common cancer in the world and pain is its most common symptom. Pain can be brought about by several different causes including local effects of the tumor, regional or distant spread of the tumor, or from anti-cancer treatment. Patients with lung cancer experience more symptom distress than patients with other types of cancer. Symptoms such as pain may be associated with worsening of other symptoms and may affect quality of life. Pain management adheres to the principles set out by the World Health Organization's analgesic ladder along with adjuvant analgesics. As pain can be caused by multiple factors, its treatment requires pharmacological and non-pharmacological measures from a multidisciplinary team linked in with specialist palliative pain management. This review article examines pain management in lung cancer

Barriers to Effective Cancer Pain Management: a Survey of Australian Family Caregivers

Cancer pain continues to be an important focus of health research and intervention development. The continuing shift of cancer care to the community increases the family caregiver's role in pain management and highlights the need to understand family experiences and also family barriers to effective pain management. This paper presents the findings of an Australian study exploring attitudinal barriers to effective pain management amongst 75 family caregivers of people with cancer attending an outpatient clinic. Approximately 75% of the caregivers demonstrated concerns or were unsure about addiction, a belief likely to impact on the use of prescribed opioids in the home. Caregivers demonstrated similar levels of concern about side-effects or whether the presence of pain indicated disease progression. These findings support research in other populations and are further evidence of the need to include family caregivers, along with patients, in intervention studies aimed at reducing the impact of these barriers on effective pain management

Conceitos culturais e a experiência dolorosa Cultural aspects and the pain experience

Este estudo objetivou verificar influência de fatores culturais na expressão do sintoma álgico. Foi baseado na avaliação de 57 pacientes com doença oncológica avançada, atendidos no serviço de radioterapia de um hospital geral, público e de ensino que experienciaram dor na semana anterior à entrevista. A duração média do quadro álgico foi 10 meses. A dor foi moderada na maioria dos doentes e intensa em cerca de 1/ 5 deles. Observou-se que concepções culturais errôneas dos doentes acerca da incontrolabilidade da dor no câncer e de que recebiam remédios em demasia, correlacionaram-se à, dor de maior intensidade (p<0,05). Este estudo mostrou que crenças errôneas relativas à dor oncológica e analgesia associaram-se a dores mais intensas.<br>The aim of this investigation was to examine the influence of cultural factors in the pain intensity. Patients presenting advanced cancer and pain, under treatment in an outpatients oncologic unit were evaluated. Pain and cultural factors were evaluated through interviews based on the use of instruments adapted to portuguese language: Patient Pain Questionnaire. Pain lasted 10 months as an average. It was moderate in the majority of patients and severe in 1/5 of them. Cultural misconceptions about the impossibility of cancer pain control and the idea that doctors prescribe excessive amount of analgesics, were correlated with higher intensities of pain (p<0,05)